Patents by Inventor Gilles Marchal

Gilles Marchal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
    Patent number: 6676945
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28.779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: January 13, 2004
    Assignee: Institut Pasteur
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
    Publication number: 20030054008
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28,799 Da, and hybrid protein containing at least portions of its sequence.
    Type: Application
    Filed: November 2, 2001
    Publication date: March 20, 2003
    Applicant: INSTITUT PASTEUR
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
    Patent number: 6379902
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28 779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: April 30, 2002
    Assignee: Institut Pasteur
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
    Patent number: 6335181
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28.779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: January 1, 2002
    Assignee: Institut Pasteur
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Antibodies Which Bind Mycobacterial Tuberculosis Proteins
    Patent number: 6221353
    Abstract: Antibodies that bind Mycobacterium tuberculosis 28 kDa proteins and immune complexes between the antibodies and proteins.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: April 24, 2001
    Assignee: Institut Pastuer
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Mycobacterium proteins and applications
    Patent number: 6060259
    Abstract: Mycobacterium proteins, in particular those of M. bovis, having molecular weights between approximately 44.5 and 47.5 kD. These proteins can have molecular weights of approximately 45 kD or 47 kD and isoelectric pH of approximately 3.7 (45 and 47 kD proteins) and 3.9 (47 kD proteins).These proteins or hybrid proteins containing a part of their sequences can be used as vaccines or as drugs, or for the detection and monitoring of tuberculosis in particular in man and in cattle.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: May 9, 2000
    Assignee: Institut Pasteur
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher, Cynthia Horn
  • Mycobacterium proteins and applications
    Patent number: 5962240
    Abstract: Mycobacterium proteins, in particular those of M. bovis, having molecular weights between approximately 44.5 and 47.5 kD. These proteins can have molecular weights of approximately 45 kD or 47 kD and isoelectric pH of approximately 3.7 (45 and 47 kD proteins) and 3.9 (47 kD proteins).These proteins or hybrid proteins containing a part of their sequences can be used as vaccines or as drugs, or for the detection and monitoring of tuberculosis in particular in man and in cattle.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: October 5, 1999
    Assignee: Institut Pasteur
    Inventors: Gilles Marchal, Felix Romain, Pascale Pescher
  • Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
    Patent number: 5866130
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 20 779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
    Type: Grant
    Filed: April 30, 1996
    Date of Patent: February 2, 1999
    Assignee: Institut Pasteur
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
    Patent number: 5714593
    Abstract: Mycobacterium tuberculosis protein having a molecular weight of 28 779 Da, and hybrid proteins containing at least portions of its sequence. These proteins may in particular be used in vaccines or for the detection of specific tuberculosis antibodies.
    Type: Grant
    Filed: February 1, 1995
    Date of Patent: February 3, 1998
    Assignee: Institut Pasteur
    Inventors: Anne Laqueyrerie, Gilles Marchal, Pascale Pescher, Felix Romain
  • Peptide sequence capable of inducing a delayed-type hypersensitivity reaction in the presence of living bacteria of the Mycobacterium tuberculosis complex and its applications
    Patent number: 5599541
    Abstract: Peptide sequence capable of initiating delayed hypersensitivity reactions of different intensity in the presence of living bacteria as opposed to dead bacteria of the Mycobacterium tuberculosis complex. The sequence is characterized in that it comprises no more than 0.5% by weight of tyrosine, phenylalanine, methionine, histidine, arginine and cysteine amino acids. The invention also concerns the diagnostic and therapeutic applications of a peptide or protein comprising said sequence.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: February 4, 1997
    Assignee: Institut Pasteur
    Inventors: Gilles Marchal, Felix Romain